SARS-CoV-2 IgM/IgG Antibody

Takaitaccen Bayani:

Wannan kit ɗin an yi niyya ne don gano ƙimar ingancin SARS-CoV-2 IgG a cikin samfuran ɗan adam na jini/plasma, jini mai jiji da jinin yatsa, gami da SARS-CoV-2 IgG antibody a cikin kamuwa da cuta ta dabi'a da al'umman rigakafin rigakafi.

Aika mana imel

Cikakken Bayani

Tags samfurin

Sunan samfur

HWTS-RT090-SARS-CoV-2 IgM/IgG Kayan Gano Maganin Jiki (Hanyar Zinare ta Colloidal)

Takaddun shaida

Epidemiology

Cutar Coronavirus 2019 (COVID-19), ciwon huhu ne da ke haifar da kamuwa da cuta tare da wani sabon labari na coronavirus mai suna Severe Acute Respiratory Syndrome Corona-Virus 2 (SARS-CoV-2). SARS-CoV-2 labari ne na coronavirus a cikin nau'in β kuma ɗan adam gabaɗaya yana da saurin kamuwa da SARS-CoV-2. Babban tushen kamuwa da cuta shine tabbatar da marasa lafiya na COVID-19 da jigilar asymptomatic na SARS-CoV-2. Dangane da binciken cututtukan cututtuka na yanzu, lokacin shiryawa shine kwanaki 1-14, galibi kwanaki 3-7. Babban bayyanar cututtuka shine zazzabi, bushewar tari, da gajiya. Ƙananan marasa lafiya suna tare da cunkoso na hanci, hanci, ciwon makogwaro, myalgia da gudawa.

Ma'aunin Fasaha

Yankin manufa	SARS-CoV-2 IgM/IgG Antibody
Yanayin ajiya	4 ℃-30 ℃
Nau'in samfurin	Serum na mutum, plasma, jini na venous da jinin yatsa
Rayuwar rayuwa	watanni 24
Kayayyakin taimako	Ba a buƙata
Karin Abubuwan Amfani	Ba a buƙata
Lokacin ganowa	10-15 min
Musamman	Babu wani ra'ayi na giciye tare da ƙwayoyin cuta, kamar Human coronavirus SARSr-CoV, MERSr-CoV, HCoV-OC43, HCoV-229E, HCoV-HKU1, HCOV-NL63, H1N1, novel mura A (H1N1) mura cutar (2009) 1, 3 seasonal H1 Flu. H7N9, mura B virus Yamagata, Victoria, numfashi syncytial virus A da B, parainfluenza virus type 1,2,3, Rhinovirus A, B, C, adenovirus irin 1,2,3,4,5,7,55.